Read the latest news from Saama.
New multi-modal GenAI solution accelerates report authoring and introduces breakthrough “Figures-to-Text” interpretation for faster, context-aware clinical insights CAMPBELL, Calif.– October 30, 2025 — Saama, an
CAMPBELL, Calif.– September 29, 2025 — Saama, an established leader in AI-driven solutions and services within Health Sciences, is introducing industry-first modular Clinical AI Agents to
CAMPBELL, Calif., June 11, 2025 – Saama, a leading provider of AI-driven solutions and services, today announced the appointment of Seshan Ramachandran as Chief Operating
CAMPBELL, Calif., December 2, 2024 – Saama, a provider of AI-based solutions that accelerate clinical development and commercialization, was again named as a Leader in
CAMPBELL, Calif. April 30, 2024 – Saama, a leader of AI-based clinical trial solutions and services that accelerate drug development and commercialization, is pleased to
CAMPBELL, Calif., February 20, 2024 – Saama today announced the appointment of Bhaskar Sambasivan as Chief Executive Officer. Sambasivan succeeds Vivek Sharma, who is stepping
CAMPBELL, Calif., February 12, 2024 – Saama, a provider of AI-based solutions that accelerate clinical development and commercialization, today announced a newly expanded, multi-year agreement with global
CAMPBELL, Calif.–(BUSINESS WIRE)–Today, Saama announced the release of several groundbreaking features within its AI-driven platform, including generative AI (GenAI) chat and interactive review listings (IRL),
CAMPBELL, Calif., October 17, 2023 – Saama, a provider of AI-based solutions that accelerate clinical development and commercialization, today announced a multi-year agreement with global
